IND-SWIFT

BSE: 524652 29 Jul 2025

Healthcare

₹ 18.92

Ind-Swift Ltd. specializes in Pharmaceuticals within the Healthcare sector.

IND-SWIFT

BSE: 524652 29 Jul 2025

Healthcare

₹ 18.92

Ind-Swift Ltd. specializes in Pharmaceuticals within the Healthcare sector.

Book Value

-122.0

Dividend Yield

0.0%

Debt to Equity

Stock P/E

1.47

Market Cap

94.5 Cr

IND-SWIFT - Share Price & Details

Market Cap

₹94.5

High /Low

34.7 / 12.0

Stock P/E

1.47

Book Value

₹-122.0

Dividend Yield

0.0

ROCE

13.4

ROE

₹NA

Face Value

2.0

PEG Ratio

-0.21

EVEBITDA

₹7.87

Debt

1,023

CMP / FCF

4.76

Debt to equity

₹NA

NP Ann

14.2

High price all time

88.2

Piotroski score

₹7.0

Graham Number

No. Eq. Shares

5.42

Net CF

₹49.8

Net profit

64.4

Price to book value

Interest Coverage

₹2.53

Low price all time

1.86

Industry PE

33.8

Reserves

₹-669

Free Cash Flow

₹-13.2

Price Chart

Volume Chart

Peer Comparison

Stock	Total Income	Net Profit	Net Sales	EPS	Market Cap (in Cr)	P/E
FABINO ENTERPRISES LIMITED	NA	NA	NA	NA	5.46	91.0
Triochem Products Ltd.,	3.25	-4.52	NA	-18.44	0
IND-SWIFT LTD.	1535.54	2565.99	1449.04	47.37	94.5	1.47
SOURCE NATURAL FOODS & HERBAL	161.24	6.27	160.65	0.97	86.9	30.0
MAKERS LABORATORIES LTD.	97.26	-14.02	97.01	-2.38	86.8	38.7

Peer Comparison Chart

About IND-SWIFT

Ind-Swift Ltd., with Security Code 524652, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.

Latest News

Ind-Swift Reports Mixed Financial Results Amidst Sales Growth and Operational Challenges in March 2025

(24 Jun 2025)

Ind-Swift has reported its financial results for the quarter ending March 2025, showcasing its highest quarterly net sales in five quarters at Rs 144.90 crore...

Ind-Swift consolidated net profit rises 583.54% in the March 2025 quarter

(24 Jun 2025)

Net profit of Ind-Swift rose 583.54% to Rs 256.60 crore in the quarter ended March 2025 as against Rs 37.54 crore during the previous quarter ended March 2024.

Quarterly Table

Standalone Consolidated

Metrics	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	106.6	105.9	148.5	115.9	102.6	135.2	113.9	136.3	120.1	144.9
Expenses	88.7	97.9	130.1	104.8	98.1	120.7	110.6	121.9	112.8	147.8
Operating Profit	17.9	8.0	18.4	11.1	4.5	14.5	3.2	14.4	7.3	-2.9
OPM %	16.79%	7.51%	12.39%	9.61%	4.38%	10.71%	2.83%	10.57%	6.1%	-1.99%
Other Income	3.2	66.9	5.6	3.2	2.6	46.6	39.9	4.6	2.6	281.3
Interest	14.8	14.5	14.9	18.3	15.3	14.4	9.5	9.5	9.9	10.2
Depreciation	7.3	7.2	6.7	6.7	6.8	6.9	5.4	5.4	5.6	7.2
Profit before tax	-1.0	-7.5	2.4	-10.7	-15.0	39.8	28.2	4.1	-5.5	-11.6
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	1.7%
Net Profit	-1.0	53.1	2.4	-10.7	-15.0	37.5	28.2	4.1	-5.5	256.6
EPS in Rs	-0.19	9.8	0.44	-1.98	-2.76	6.93	5.21	0.76	-1.02	47.37

Metrics	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	103.8	106.6	105.9	148.5	115.9	102.6	135.2	113.9	136.3	120.1
Expenses	92.9	88.7	97.9	130.1	104.8	98.1	120.7	110.6	121.9	112.8
Operating Profit	10.9	17.9	8.0	18.4	11.1	4.5	14.5	3.2	14.4	7.3
OPM %	10.52%	16.79%	7.51%	12.39%	9.61%	4.38%	10.71%	2.83%	10.57%	6.1%
Other Income	1.0	3.2	66.9	5.6	3.2	2.6	46.6	39.9	4.6	2.6
Interest	15.4	14.8	14.5	14.9	18.3	15.3	14.4	9.5	9.5	9.9
Depreciation	7.1	7.3	7.2	6.7	6.7	6.8	6.9	5.4	5.4	5.6
Profit before tax	-10.6	-1.0	-7.5	2.4	-10.7	-15.0	39.8	28.2	4.1	-5.5
Tax %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Profit	-10.6	-1.0	53.1	2.4	-10.7	-15.0	37.5	28.2	4.1	-5.5
EPS in Rs	-1.96	-0.19	9.8	0.44	-1.98	-2.76	6.93	5.21	0.76	-1.02

Shareholding Distribution

Shareholding Pattern

Compounded Data

Consolidated

Standalone

Compounded Sales Growth
10 Years:	-1%
5 Years:	12%
3 Years:	12%
TTM:	7%

Compounded Profit Growth
10 Years:	6%
5 Years:	-7%
3 Years:	5%
TTM:	309%

Stock Price CAGR
10 Years:	11%
5 Years:	48%
3 Years:	13%
1 Year:	-34%

Compounded Sales Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	7%

Compounded Profit Growth
10 Years:	0%
5 Years:	0%
3 Years:	0%
TTM:	309%

Stock Price CAGR
10 Years:	11%
5 Years:	48%
3 Years:	13%
1 Year:	-34%

All Deals

Date	Stock	Party	Deal	Acq. Mode	Trans.	Quan.	Price	Value

IND-SWIFT

IND-SWIFT

IND-SWIFT - Share Price & Details

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

About IND-SWIFT

Latest News

Ind-Swift Ltd leads gainers in 'B' group

Why is Ind-Swift Labs. falling/rising?

Ind-Swift Laboratories Ensures Compliance with SEBI Regulations

Orbit Exports Ltd leads gainers in 'B' group

Ind-Swift Reports Mixed Financial Results Amidst Sales Growth and Operational Challenges in March 2025

Ind-Swift consolidated net profit rises 583.54% in the March 2025 quarter

There's No Escaping Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Muted Revenues Despite A 46% Share Price Rise

Has Ind-Swift Labs. declared dividend?

Has Ind-Swift declared dividend?

Ind-Swift Labs and 2 other stocks in focus following significant bulk deal transactions

Bulk & Block deals: Goldman Sachs India Equity Portfolio purchases 0.7% stake in TD Power on May 22

Bulk & Block deals: Goldman Saschs sells 3.5 lakh shares of One 97 Communications

Ind-Swift Faces Financial Struggles Amidst Ongoing Market Volatility and Declining Performance

Ind-Swift Faces Financial Struggles Amid Significant Stock Volatility and Declining Performance

Improved Revenues Required Before Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Shares Find Their Feet

2 Stocks under ₹80 in focus after shares worth up to ₹2.44 Cr exchange hands via Bulk Deal

Ind-Swift Ltd Experiences Notable Buying Surge Amid Recent Price Gains

Ind-Swift Faces Financial Scrutiny Amid Significant Stock Decline and Weak Fundamentals

5 High Book Value Penny Stocks to Watch Out for in 2025

Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress

Ind-Swift Reports Flat Q3 FY24-25 Results Amid Declining Evaluation Score

Ind-Swift Adopts New Code for Insider Trading Regulation

Ind-Swift Laboratories (NSE:INDSWFTLAB) delivers shareholders massive 36% CAGR over 5 years, surging 11% in the last week alone

NCLT directs Ind-Swift Ltd to convene shareholder meetings for merger with Ind Swift Laboratories

Manoj Vaibhav Gems N Jewellers Ltd leads gainers in 'B' group

Lords Chloro Alkali Ltd leads gainers in 'B' group

What are ASM and ASM List in the Share Market?

IND. SWIFT Share Price Today Up 7%

Abans Holdings Ltd leads losers in 'B' group

Stock market update: Nifty Pharma index 0.56%

Stock market update: Nifty Auto index 0.77%

Ind-Swift Experiences Revision in Stock Evaluation Amid Recent Market Volatility

Pharma stock hits 5% upper circuit after announcing setup of R&D center in Punjab

Sensex falls! But these stocks are up over 10% on BSE

Stock market update: Stocks that hit 52-week highs on NSE in today's trade

Umang Dairies Ltd leads gainers in 'B' group

There Are Some Reasons To Suggest That Ind-Swift Laboratories' (NSE:INDSWFTLAB) Earnings Are A Poor Reflection Of Profitability

Ind-Swift reports consolidated net profit of Rs 4.11 crore in the September 2024 quarter

Ind-Swift Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) Revenues Are Not Doing Enough For Some Investors

Ind Swift Laboratories opens marketing office in New Delhi

Don't Ignore The Insider Selling In Ind-Swift Laboratories

Ind-Swift Consolidated June 2024 Net Sales at Rs 113.85 crore, down 23.35% Y-o-Y

Ind-Swift Standalone June 2024 Net Sales at Rs 113.85 crore, down 23.35% Y-o-Y

Ind-Swift Labs Standalone June 2024 Net Sales at Rs 30.46 crore, down 89.81% Y-o-Y

Ind-Swift consolidated net profit rises 1096.61% in the June 2024 quarter

Ind-Swift Laboratories Q1 Results Live : profit falls by 94.57% YOY | Company Business News

Ind-Swift Laboratories Q1 Results Live : profit falls by 94.57% YOY

Court frames charges against five accused in multi-crore VAT scam

IND SWIFT LA Share Price Today Up 20%

Private companies among Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) largest shareholders, saw gain in holdings value after stock jumped 12% last week

Top stocks giving multi-year breakouts

Ind-Swift Laboratories Limited (NSE:INDSWFTLAB) Stock Rockets 29% But Many Are Still Ignoring The Company

Ind-Swift Laboratories' (NSE:INDSWFTLAB) 32% CAGR outpaced the company's earnings growth over the same five-year period

Ind-Swift Labs board to mull fund raising

ANG Lifesciences India updates on acquisition of unit from Ind-Swift

Ind-Swift Laboratories Downgraded to 'Sell' by MarketsMOJO Due to Weak Fundamental Strength

SEBI imposes Rs10 lakh penalty on individual in Ind-Swift Lab case

Ind-Swift Labs Standalone March 2024 Net Sales at Rs 381.73 crore, up 31.41% Y-o-Y

Ind-Swift Laboratories Receives 'Sell' Rating from MarketsMOJO Due to Weak Long-Term Outlook

Is Ind-Swift Laboratories Limited's (NSE:INDSWFTLAB) 5.9% ROE Worse Than Average?

Bulk deals: EC Special Situations fund sells stake in Ind Swift Labs, Societe Generale buys stake in Sat...

Ind-Swift Laboratories Share Price

IndiaRF Fund borrows Rs 700 crore from Axis Bank for Ind Swift buyout

Ind-Swift Share Price Today - Live Ind-Swift Ltd. Share Price and Stock Updates on NSE/BSE

CMD of IND-SWIFT LABORATORIES LTD conferred with award by IDMA

Here's Why Ind-Swift Laboratories (NSE:INDSWFTLAB) Can Manage Its Debt Responsibly

Ind-Swift Laboratories receives award from World HRD Congress

CCI approves acquisition of certain business undertakings of Ind Swift Labs, Essix Biosciences by...

CCI clears Synthimed Labs proposal to buy ISLL, Essix Biosciences businesses

CCI Clears Synthimed Labs Proposal To Buy ISLL, Essix Biosciences Businesses